Thomas D. Nolin, PharmD (’99), PhD (’03), FCCP, FCP, FASN was the keynote lecturer at the European NephroPharmacology 2015 meeting held October 10, 2015 in Heidelberg, Germany. The title of his presentation was Drug Dose Adjustment of Non-Renally Eliminated Drugs in CKD Patients – What is the Evidence?
Nolin is an NIH funded investigator whose clinical and translational research focuses on the impact of kidney disease on nonrenal drug clearance mediated by metabolizing enzymes and transport proteins.
Nolin is an assistant professor in the department of pharmacy and therapeutics and member of the Center for Clinical Pharmaceutical Sciences at PittPharmacy.
